A pitfall in hemoglobin A1c measurement with high performance liquid chromatography method in the diagnosis of onset of fulminant type 1 diabetes mellitus.


Journal

Journal of diabetes investigation
ISSN: 2040-1124
Titre abrégé: J Diabetes Investig
Pays: Japan
ID NLM: 101520702

Informations de publication

Date de publication:
Nov 2022
Historique:
revised: 09 05 2022
received: 07 04 2022
accepted: 16 05 2022
pubmed: 28 5 2022
medline: 3 11 2022
entrez: 27 5 2022
Statut: ppublish

Résumé

We showed a case with the onset of fulminant type 1 diabetes mellitus (FT1DM) whose HbA1c could not be measured with HPLC method. We think that the reason why his HbA1c was not be detected was associated with the presence of labile hemoglobin A1c (LHbA1c). These result mean that it is possible that LHbA1c can bring about a pitfall on HPLC method in diagnosis of onset of FT1DM.

Identifiants

pubmed: 35620974
doi: 10.1111/jdi.13834
pmc: PMC9623534
doi:

Substances chimiques

Glycated Hemoglobin A 0

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

1943-1944

Informations de copyright

© 2022 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.

Références

N Engl J Med. 2000 Feb 3;342(5):301-7
pubmed: 10655528
Curr Opin Endocrinol Diabetes Obes. 2009 Apr;16(2):113-8
pubmed: 19300091
Anal Biochem. 2012 May 15;424(2):149-55
pubmed: 22370282
Clin Chem Lab Med. 2012 Oct 1;50(10):1769-75
pubmed: 23089707

Auteurs

Yasuharu Oe (Y)

Department of Clinical Laboratory, Kawasaki Medical School General Medical Center, Okayama, Japan.

Takatoshi Anno (T)

Department of General Internal Medicine 1, Kawasaki Medical School, Okayama, Japan.

Yukari Katsuhara (Y)

Department of Clinical Laboratory, Kawasaki Medical School General Medical Center, Okayama, Japan.

Ryo Sugahara (R)

Department of Clinical Laboratory, Kawasaki Medical School General Medical Center, Okayama, Japan.

Miki Kobayashi (M)

Department of Clinical Laboratory, Kawasaki Medical School General Medical Center, Okayama, Japan.

Mieko Yakusue (M)

Department of Clinical Laboratory, Kawasaki Medical School General Medical Center, Okayama, Japan.

Masayo Tamura (M)

Department of Clinical Laboratory, Kawasaki Medical School General Medical Center, Okayama, Japan.

Yukiko Kimura (Y)

Department of General Internal Medicine 1, Kawasaki Medical School, Okayama, Japan.

Fumiko Kawasaki (F)

Department of General Internal Medicine 1, Kawasaki Medical School, Okayama, Japan.

Kohei Kaku (K)

Department of General Internal Medicine 1, Kawasaki Medical School, Okayama, Japan.

Hideaki Kaneto (H)

Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Kurashiki, Japan.

Akira Kitanaka (A)

Department of Clinical Laboratory, Kawasaki Medical School General Medical Center, Okayama, Japan.
Department of Laboratory Medicine, Kawasaki Medical School, Kurashiki, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH